Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests – mersidistribution

Our payment gateway is currently down. Please email wowsupport@mersidistribution.com to place an order or call (800) 654-0186 during business hours. We anticipate resolving this issue within 24-48 hours. Apologies for any inconvenience caused!

Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests
  • Load image into Gallery viewer, Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests

Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests

new

SKU: RCHM-02071P

The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.

UOM: Pallet (20 tests/box, 32 boxes/cs, 20 cases per pallet)

Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.

Product Features:

  • Lateral flow assay
  • Rapid results in 10 minutes
  • Anterior nare (nasal) specimen collection
  • Intended at POC setting (i.e., in patient care settings) by medical professionals with a CLIA waiver
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection with 87.2% sensitivity and 100% specificity
  • Storage condition: 1-30 degrees celsius
Specifications
Test type Lateral flow immunochromatographic assay
Specimen type Anterior nasal (AN)
Turnaround time 10 minutes
CLIA complexity Waived, Moderate, or High complexity
FDA status Emergency Use Authorization (EUA) granted
Packaging
20 tests/box, 32 boxes/cs, 20 cases per pallet
Resources

The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike. Please view the product guide entitled "EUA Amendment" to read about the product's expiration extension.

UOM: Pallet (20 tests/box, 32 boxes/cs, 20 cases per pallet)

Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.

Product Features:

  • Lateral flow assay
  • Rapid results in 10 minutes
  • Anterior nare (nasal) specimen collection
  • Intended at POC setting (i.e., in patient care settings) by medical professionals with a CLIA waiver
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection with 87.2% sensitivity and 100% specificity
  • Storage condition: 1-30 degrees celsius
Specifications
Test type Lateral flow immunochromatographic assay
Specimen type Anterior nasal (AN)
Turnaround time 10 minutes
CLIA complexity Waived, Moderate, or High complexity
FDA status Emergency Use Authorization (EUA) granted
Packaging
20 tests/box, 32 boxes/cs, 20 cases per pallet
Resources


Pallet of CareStart™ COVID-19 Antigen test - 12,800 tests Price List

Store Price